About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Team (5)
Clinical Trials (21)
View allTotal Trials
21
As Lead Sponsor
21
As Collaborator
0
Total Enrollment
3,637
By Phase
PHASE3: 5PHASE2: 13PHASE2/PHASE3: 1PHASE1/PHASE2: 2
By Status
COMPLETED: 14RECRUITING: 3WITHDRAWN: 2NOT_YET_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline21 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06643260Lead Sponsor
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
PHASE3Not yet recruiting
705 participants
Started: Jun 30, 2025 · Completed: Jun 30, 2028
NCT06387342Lead Sponsor
Namodenoson Treatment of Advanced Pancreatic Cancer
PHASE2Recruiting
20 participants
Started: Nov 10, 2024 · Completed: Dec 15, 2026
NCT05201404Lead Sponsor
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
PHASE3Recruiting
471 participants
Started: Mar 15, 2023 · Completed: Oct 31, 2026
NCT04697810Lead Sponsor
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
PHASE2Recruiting
114 participants
Started: Dec 10, 2021 · Completed: Oct 15, 2025
NCT04333472Lead Sponsor
Piclidenoson for Treatment of COVID-19
PHASE2Completed
6 participants
Started: Jan 6, 2021 · Completed: Apr 21, 2022
Locations (1)
Headquarters
Petach Tikva, Israel
Map
Loading map...